A 48-week study of amlodipine plus amiloride/hydrochlorothiazide vs. amlodipine plus telmisartan in the treatment of hypertension

International Journal of Clinical Practice

Volumn 66, Issue 8, 2012, Pages 792-799

  Lu, F ^a   Zhao, Y ^a,b   Liu, Z ^a   Sun, H ^b   Sun, S ^a   Wang, S ^a  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMILORIDE PLUS AMLODIPINE PLUS HYDROCHLOROTHIAZIDE; AMLODIPINE PLUS TELMISARTAN; ANTIHYPERTENSIVE AGENT; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD PRESSURE REGULATION; CHINA; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISEASE SEVERITY; DIZZINESS; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG FATALITY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPEPSIA; FACIAL NERVE PARALYSIS; FATIGUE; FEMALE; HUMAN; HYPERKALEMIA; HYPERTENSION; HYPOKALEMIA; HYPONATREMIA; HYPOTENSION; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PERIPHERAL EDEMA; PRIORITY JOURNAL; PULSE RATE; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SUPRAVENTRICULAR PREMATURE BEAT; TREATMENT RESPONSE;

EID: 84863930694     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2012.02943.x     Document Type: Article

References (29)

1. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R,. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903-13. (Pubitemid 35472129)
2. Wu Y, Huxley R, Li L, et al., China NNHS Steering Committee; China NNHS Working Group. Prevalence, awareness, treatment, and control of hypertension in China: data from the China National Nutrition and Health Survey 2002. Circulation 2008; 118: 2679-86.
3. Lopez VA, Franklin SS, Tang S, et al., Coronary heart disease events preventable by control of blood pressure and lipids in US adults with hypertension. J Clin Hypertens (Greenwich) 2007; 9: 436-43.
4. Yang J, Lu F, Zhang C, et al., Prevalence of prehypertension and hypertension in a Chinese rural area from 1991 to 2007. Hypertens Res 2010; 33: 331-7.
5. Chobanian AV, Bakris GL, Black HR, et al., National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003; 289: 2560-72. (Pubitemid 37430158)
6. Mancia G, De Backer G, Dominiczak A, et al., ESH-ESC Task Force on the Management of Arterial Hypertension. 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the management of arterial hypertension. J Hypertens 2007; 25: 1751-62. (Pubitemid 47356612)
7. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317: 703-13.
8. Brenner BM, Cooper ME, de Zeeuw D, et al., RENAAL Study Investigators. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001; 345: 861-9.
9. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288: 2981-97.
10. Dahlöf B, Sever PS, Poulter NR, et al., ASCOT Investigators. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet 2005; 366: 895-906. (Pubitemid 41265663)
11. Atkins RC, Briganti EM, Lewis JB, et al., Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy. Am J Kidney Dis 2005; 45: 281-7. (Pubitemid 40431053)
12. Jamerson K, Weber MA, Bakris GL, et al., ACCOMPLISH Trial Investigators. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 2008; 359: 2417-28.
13. Chrysant SG, Melino M, Karki S, et al., The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety study. Clin Ther 2008; 30: 587-604. (Pubitemid 351680489)
14. White WB, Littlejohn TW, Majul CR, et al., Effects of telmisartan and amlodipine in combination on ambulatory blood pressure in stages 1-2 hypertension. Blood Press Monit 2010; 15: 205-12.
15. Philipp T, Smith TR, Glazer R, et al., Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension. Clin Ther 2007; 29: 563-80. (Pubitemid 47028551)
16. Wang W, Ma L, Zhang Y, et al., The combination of amlodipine and angiotensin receptor blocker or diuretics in high-risk hypertensive patients: rationale, design and baseline characteristics. J Hum Hypertens 2011; 25: 271-7.
17. Committee for Revision of Chinese Guidelines for Prevention and Treatment of Patients with Hypertension. Chinese guidelines for prevention and treatment of patients with hypertension [in Chinese]. Chin J Hypertens 2005; 134 (Suppl): S2-41.
18. Epstein BJ, Vogel K, Palmer BF,. Dihydropyridine calcium channel antagonists in the management of hypertension. Drugs 2007; 67: 1309-27. (Pubitemid 46879096)
19. Calhoun DA, Lacourcière Y, Chiang YT, et al., Triple antihypertensive therapy with amlodipine, valsartan, and hydrochlorothiazide: a randomized clinical trial. Hypertension 2009; 54: 32-9.
20. Littlejohn TW 3rd, Majul CR, Olvera R, et al., Study Investigators. Results of treatment with telmisartan-amlodipine in hypertensive patients. J Clin Hypertens (Greenwich) 2009; 11: 207-13.
21. Zidek W, Naditch-Brûlé L, Perlini S, et al., Blood pressure control and components of the metabolic syndrome: the GOOD survey. Cardiovasc Diabetol 2009; 8: 51-9.
22. Cooper-DeHoff RM, Gong Y, Handberg EM, et al., Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease. JAMA 2010; 304: 61-8.
23. ACCORD Study Group, Cushman WC, Evans GW, Byington RP, et al., Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 2010; 362: 1575-85.
24. MRC/BHF Heart Protection Study Collaborative Group, Armitage J, Bowman L, Collins R, et al., Effects of simvastatin 40 mg daily on muscle and liver adverse effects in a 5-year randomized placebo-controlled trial in 20,536 high-risk people. BMC Clin Pharmacol 2009; 9: 6-15.
25. Smith TR, Glazer RD, Koren MJ, et al., Combination therapy with amlodipine/valsartan in essential hypertension: a 52-week, randomised, open-label, extension study. Int J Clin Pract 2010; 64: 1367-74.
26. Fogari R, Malamani GD, Zoppi A, et al., Effect of benazepril addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patients. J Hum Hypertens 2003; 17: 207-12. (Pubitemid 36388805)
27. Fogari R, Zoppi A, Derosa G, et al., Effect of valsartan addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patients. J Hum Hypertens 2007; 21: 220-4.
28. Volpe M, Miele C, Haag U,. Efficacy and safety of a stepped-care regimen using olmesartan medoxomil, amlodipine and hydrochlorothiazide in patients with moderate-to-severe hypertension: an open-label, long-term study. Clin Drug Investig 2009; 29: 381-91.
29. Volpe M, Brommer P, Haag U, et al., Efficacy and tolerability of olmesartan medoxomil combined with amlodipine in patients with moderate to severe hypertension after amlodipine monotherapy: a randomized, double-blind, parallel-group, multicentre study. Clin Drug Investig 2009; 29: 11-25.